Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice. | Acta Pharmacol Sin | 2023 | 37402997 | PubTator, text mining | PubMed |
| Reduction in sugar drink valuation and consumption with gamified executive control training. | Sci Rep | 2023 | 37391448 | PubTator, text mining | PubMed |
| Homotypic SCOTIN assemblies form ER-endosome membrane contacts and regulate endosome dynamics. | EMBO Rep | 2023 | 37377038 | PubTator, text mining | PubMed |
| Assessing Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury: Animal Models in Preclinical Neuro-Urology Research. | Biomedicines | 2023 | 37371634 | PubTator, text mining | PubMed |
| Polymeric Based Hydrogel Membranes for Biomedical Applications. | Membranes (Basel) | 2023 | 37367780 | PubTator, text mining | PubMed |
| How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis? | Front Cell Neurosci | 2023 | 37361998 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
| Cell transplantation therapies for spinal cord injury focusing on bone marrow mesenchymal stem cells: Advances and challenges. | World J Stem Cells | 2023 | 37342219 | PubTator, text mining | PubMed |
| RTN3 and RTN4: Architects of SARS-CoV-2 replication organelles. | J Cell Biol | 2023 | 37318453 | PubTator, text mining | PubMed |
| Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. | Acta Neuropathol Commun | 2023 | 37309012 | PubTator, text mining | PubMed |
| Therapeutic Strategies Targeting Respiratory Recovery after Spinal Cord Injury: From Preclinical Development to Clinical Translation. | Cells | 2023 | 37296640 | PubTator, text mining | PubMed |
| Tackling the glial scar in spinal cord regeneration: new discoveries and future directions. | Front Cell Neurosci | 2023 | 37293626 | PubTator, text mining | PubMed |
| A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities. | Mil Med Res | 2023 | 37291666 | PubTator, text mining | PubMed |
| The role of noncoding genetic variants in cardiomyopathy. | Front Cardiovasc Med | 2023 | 37283586 | PubTator, text mining | PubMed |
| Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease. | Front Aging Neurosci | 2023 | 37266401 | PubTator, text mining | PubMed |
| Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. | Front Mol Neurosci | 2023 | 37266374 | PubTator, text mining | PubMed |
| Central nervous system demyelinating diseases: glial cells at the hub of pathology. | Front Immunol | 2023 | 37261349 | PubTator, text mining | PubMed |
| Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers. | Aging (Albany NY) | 2023 | 37253634 | PubTator, text mining | PubMed |
| Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway. | Int Immunopharmacol | 2023 | 37244119 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=11